Norkolut - progestogen.
The composition and the form of Norkoluta
The drug comes in the form of round white tablets. One tablet contains:
- active ingredient - norethisterone 5 mg;
- Auxiliary components: lactose monohydrate, corn starch, gelatin, potato starch, talc, magnesium stearate, colloidal silicon dioxide.
Norethisterone acting drug substance refers to a progestogen and to a lesser extent has the properties of estrogen and androgen.
Admission Norkoluta causes transformation of the endometrium in the secretory phase of the proliferative phase, prevents ovulation and maturation of the follicles, blocking the secretion of gonadotropin in the pituitary gland.
According to the instructions Norkolut shown at:
- premenstrual syndrome;
- progesterone diagnostic test;
- endometrial hyperplasia;
- anovulatory metrorrhagia;
- uterine cancer.
It is also used for Norkolut instructions for the prevention and cessation of lactation.
Dosing and dosing Norkoluta
According to the instructions Norkolut ingested.
Reception at Norkoluta mastodynia and ICP performed in the period from 16 to 25 day menstrual cycle of 1-2 tablets per day. Allowed to use Norkoluta in combination with estrogen.
When uterine fibroids take 1-2 tablets a day with a 5 to 25 day cycle. Duration of Norkoluta is no longer than six months.
In endometriosis take 1 tablet per day Norkoluta 5 to 25 loop for six months.
When anovulatory metrorrhagia and endometrial hyperplasia take 1-2 tablets a day for 6 to 12 days. After achieving a therapeutic effect reception Norkoluta 1-2 tablets made between 16 and 25 days of the cycle, usually in combination with estrogen, to avoid recurrence.
For a diagnostic test for progesterone instructions Norkolut prescribed at a dose of 2 tablets per day for 10 days. Normally, 3-7 days after receiving Norkoluta should appear spotting and last 3-4 days.
To stop the lactation designate: 4 tablets per day with 1 to 3 day 3 tablets - from 4 to 7 days, 2 tablets - from 8 to 10 days.
According to the instructions Norkolut is contraindicated in:
- bleeding from the genital tract of unknown etiology;
- malignant tumors of the female genital organs;
- bleeding from the urinary tract of unknown etiology;
- breast cancer;
- acute thrombophlebitis or thromboembolic;
- acute liver disease;
- tendency to thrombosis;
- impaired renal function or liver;
- hypersensitivity to the drug.
In the opinion of Norkolut be used with caution when:
- renal insufficiency;
- thrombophlebitis in history;
- violation of the central nervous system;
- congestive heart failure;
- liver disease;
In the opinion of Norkolut cause the following side effects:
- vomiting, nausea;
- acyclic spotting from the vagina;
- allergic reactions;
- weight gain;
- tension of the mammary glands;
Norkolut reviews for patients in long-term use may cause thromboembolism, thrombosis.
Application Norkoluta during pregnancy and lactation
Admission Norkoluta contraindicated during pregnancy.
In the early period of pregnancy accidental use Norkoluta Review has no teratogenic effects, as well as violations of the limbs and heart.
During lactation Norkolut not be taken, as it reduces the secretion of milk and affects its quality indicators.
Storage conditions and shelf life Norkoluta
The drug Norkolut stored in a dry place inaccessible to children at temperature not above 30 ° C. Shelf life of five years.